ABEONA THERAPEUTICS INC. Adjustments to Additional Paid in Capital, Warrant Issued
ABEONA THERAPEUTICS INC. (ABEO) reported Adjustments to Additional Paid in Capital, Warrant Issued of $7.05 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-17
- ABEONA THERAPEUTICS INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-12-31 was $2.14M.
- ABEONA THERAPEUTICS INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-09-30 was $4.91M, a 332.69% increase year-over-year.
- ABEONA THERAPEUTICS INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-12-31 was $0.00.
- ABEONA THERAPEUTICS INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-09-30 was $1.14M.
- ABEONA THERAPEUTICS INC. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $7.05M, a 521.41% increase from fiscal 2024.
- ABEONA THERAPEUTICS INC. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $1.14M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $7.05M derived: sum of 2 quarters · filed 2026-03-17 | $7.05M 10-K · filed 2026-03-17 | |
| 2025-09-30 | $4.91M 10-Q · filed 2025-11-12 | $4.91M 10-Q · filed 2025-11-12 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $1.14M derived: sum of 2 quarters · filed 2026-03-17 | $1.14M 10-K · filed 2026-03-17 | |
| 2024-09-30 | $1.14M 10-Q · filed 2025-11-12 | $1.14M 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |